Insider Trading Alert - CAH, PMT And KS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, May 14, 2014, 169 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $109.00 to $76,434,960.75.

Highlighted Stocks Traded by Insiders:

Cardinal Health (CAH) - FREE Research Report

Blake Mark R, who is EVP - Strategy & Corp. Dev. at Cardinal Health, sold 2,822 shares at $66.50 on May 14, 2014. Following this transaction, the EVP - Strategy & Corp. Dev. owned 29,119 shares meaning that the stake was reduced by 8.84% with the 2,822-share transaction.

The shares most recently traded at $64.77, down $1.73, or 2.67% since the insider transaction. Historical insider transactions for Cardinal Health go as follows:

  • 4-Week # shares sold: 27,031
  • 12-Week # shares sold: 27,031
  • 24-Week # shares sold: 113,890

The average volume for Cardinal Health has been 2.2 million shares per day over the past 30 days. Cardinal Health has a market cap of $22.5 billion and is part of the services sector and wholesale industry. Shares are down 2.38% year-to-date as of the close of trading on Wednesday.

Cardinal Health, Inc., a healthcare services company, provides pharmaceutical and medical products and services in the United States and internationally. The company operates in two segments, Pharmaceutical and Medical. The stock currently has a dividend yield of 2.07%. The company has a P/E ratio of 66.8. Currently, there are 12 analysts who rate Cardinal Health a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CAH - FREE

TheStreet Quant Ratings rates Cardinal Health as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Cardinal Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

These Stocks Pay You to Own Them

FDA Official Calls for Ending Codeine Use in Kids Cough Products

Big Drug Makers Could Face More Pressure on Codeine Remedies for Kids

Cramer: Finding the Flaws in Amazon

Cardinal Health: Cramer's Top Takeaways